Quarterly report pursuant to Section 13 or 15(d)

Nature of Business and Liquidity Nature of Business and Liquidity (Details)

v3.10.0.1
Nature of Business and Liquidity Nature of Business and Liquidity (Details)
9 Months Ended
Sep. 30, 2018
technology
candidate
site
project
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of core drug technologies | technology 3
Number of drug candidates 6
Number of drugs in clinical trials 2
Number of clinical trials 3
Number of other drug development projects | project 5
Number of recruitment sites | site 4